Clinical Trial Update: Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a regimen of Lopinavir/Ritonavir and Lamivudine versus standard therapy in treatment-naive HIV-1–infected subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)
• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: Pedro Cahn | Conditions: HIV Infection | Phase 3 | Status: COMPLETED